Danish pharmaceutical company Novo Nordisk is one of Europe's brightest stars. With its popular weight-loss drugs, Novo Nordisk became the second European company to hit $500 billion in market value this year. However, the Estonian branch of the company received a warning about possible deletion from the Commercial Register. According to Delfi Ärileht, another large wave of liquidations may be coming.